Background: The fixed-dose combination containing the antihypertensive agent amlodipine
and the statin, atorvastatin, is the first combination of its kind designed to treat two risk factors …

The aim was to evaluate the efficacy of a single-pill combination of atorvastatin/amlodipine
in patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk …

Therapies that lower blood pressure or lipid levels slow the progression of atherosclerosis,
and reduce morbidity and mortality in patients with hypertension or atherosclerotic disease …

The Gemini Study was a 14‐week, open‐label, noncomparative, office‐based, multicenter
trial to evaluate single‐pill therapy in the treatment of concomitant hypertension and …

Abstract The Gemini-AALA (Australia, Asia, Latin America, Africa/Middle East) study
evaluated the efficacy and safety of single-pill amlodipine/atorvastatin (Caduet) for the …

Hypertension (HTN) and dyslipidemia (DYS) commonly coexist. Patients with concurrent
HTN and DYS are at high risk of cardiovascular disease, yet most patients do not achieve …

The authors performed this study to investigate the efficacy and safety of a rosuvastatin
(RSV)/amlodipine (AML) polypill compared with those of atorvastatin (ATV)/AML polypill. We …

There is paucity of information regarding the effects of combination therapy with amlodipine
and hydrochlorothiazide on lipid profiles in hypertensive Nigerians. Therefore, to evaluate …

Guidelines stress the importance of the simultaneous management of multiple
cardiovascular risk factors. This can in part be achieved by coadministration of lipid …

The AVALON study was a randomized, multicenter trial to assess the efficacy and safety of
coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia …